Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Livzon Pharmaceutical Group ( (HK:1513) ).
Livzon Pharmaceutical Group has announced a capital contribution to LivzonBio to address its capital needs without incurring additional borrowings and interest expenses. This financial support follows the valuation methodology used in previous reorganizations and investments, ensuring consistency and stability in the company’s financial strategy.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. is a company operating in the biopharmaceutical industry. It is primarily engaged in the research, development, and commercialization of biopharmaceutical products, with a focus on innovative therapies. The company operates through its subsidiaries, including Livzon Biologics Limited and Livzon MABPharm Inc.
Average Trading Volume: 952,284
Technical Sentiment Signal: Buy
Current Market Cap: HK$30.59B
For detailed information about 1513 stock, go to TipRanks’ Stock Analysis page.